Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Adma Biologics (ADMA) Other Non Operating Income: 2018-2025

Historic Other Non Operating Income for Adma Biologics (ADMA) over the last 8 years, with Sep 2025 value amounting to -$2.2 million.

  • Adma Biologics' Other Non Operating Income fell 3787.50% to -$2.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year increase of 103.86%. This contributed to the annual value of $4.3 million for FY2024, which is 116.58% up from last year.
  • Per Adma Biologics' latest filing, its Other Non Operating Income stood at -$2.2 million for Q3 2025, which was down 81.42% from -$1.2 million recorded in Q2 2025.
  • In the past 5 years, Adma Biologics' Other Non Operating Income ranged from a high of $4.4 million in Q4 2024 and a low of -$26.0 million during Q4 2023.
  • Moreover, its 3-year median value for Other Non Operating Income was -$56,000 (2024), whereas its average is -$2.3 million.
  • In the last 5 years, Adma Biologics' Other Non Operating Income surged by 170.14% in 2021 and then plummeted by 44,047,357.63% in 2023.
  • Over the past 5 years, Adma Biologics' Other Non Operating Income (Quarterly) stood at -$145,228 in 2021, then surged by 99.96% to -$59 in 2022, then tumbled by 44,047,357.63% to -$26.0 million in 2023, then soared by 117.11% to $4.4 million in 2024, then crashed by 3,787.50% to -$2.2 million in 2025.
  • Its Other Non Operating Income stands at -$2.2 million for Q3 2025, versus -$1.2 million for Q2 2025 and -$64,000 for Q1 2025.